313 related articles for article (PubMed ID: 25438529)
1. [Effects of daily consumption of milk powder on menstrual cycles and urine sex hormone concentrations of young women].
Zhang M; Ju J; Wang Z; Wu J; Geng S; Liu J; Yang Y
Wei Sheng Yan Jiu; 2014 Sep; 43(5):754-8. PubMed ID: 25438529
[TBL] [Abstract][Full Text] [Related]
2. Monitoring of ovarian activity by daily measurement of urinary excretion rates of oestrone glucuronide and pregnanediol glucuronide using the Ovarian Monitor, Part III: variability of normal menstrual cycle profiles.
Blackwell LF; Vigil P; Cooke DG; d'Arcangues C; Brown JB
Hum Reprod; 2013 Dec; 28(12):3306-15. PubMed ID: 24170744
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of ovulation by low-dose mifepristone (RU 486).
Ledger WL; Sweeting VM; Hillier H; Baird DT
Hum Reprod; 1992 Aug; 7(7):945-50. PubMed ID: 1331167
[TBL] [Abstract][Full Text] [Related]
4. The effect of RU486 administered during the proliferative and secretory phase of the cycle on the bleeding pattern, hormonal parameters and the endometrium.
Swahn ML; Johannisson E; Daniore V; de la Torre B; Bygdeman M
Hum Reprod; 1988 Oct; 3(7):915-21. PubMed ID: 2846630
[TBL] [Abstract][Full Text] [Related]
5. Postpartum return of ovarian activity in nonbreastfeeding women monitored by urinary assays.
Gray RH; Campbell OM; Zacur HA; Labbok MH; MacRae SL
J Clin Endocrinol Metab; 1987 Apr; 64(4):645-50. PubMed ID: 3818896
[TBL] [Abstract][Full Text] [Related]
6. The prediction and/or detection of ovulation by means of urinary steroid assays.
Cekan SZ; Beksac MS; Wang E; Shi S; Masironi B; Landgren BM; Diczfalusy E
Contraception; 1986 Apr; 33(4):327-45. PubMed ID: 3731775
[TBL] [Abstract][Full Text] [Related]
7. Late luteal phase administration of RU486 for three successive cycles does not disrupt bleeding patterns or ovulation.
Croxatto HB; Salvatierra AM; Romero C; Spitz IM
J Clin Endocrinol Metab; 1987 Dec; 65(6):1272-7. PubMed ID: 3119656
[TBL] [Abstract][Full Text] [Related]
8. Monitoring the menstrual cycle: Comparison of urinary and serum reproductive hormones referenced to true ovulation.
Roos J; Johnson S; Weddell S; Godehardt E; Schiffner J; Freundl G; Gnoth C
Eur J Contracept Reprod Health Care; 2015; 20(6):438-50. PubMed ID: 26018113
[TBL] [Abstract][Full Text] [Related]
9. Ovulatory status and menstrual cycle duration assessed by self-collection of urine on pH strips in a population-based sample of French women not using hormonal contraception.
Rosetta L; Thalabard JC; Tanniou J; Ducot B; Maitrot-Mantelet L; Rousset-Jablonski C; Bohet A; Bouyer J; Chimenes A; Slama R
Eur J Contracept Reprod Health Care; 2017 Dec; 22(6):450-458. PubMed ID: 29260590
[TBL] [Abstract][Full Text] [Related]
10. Methods of monitoring menstrual function in field studies: efficacy of methods.
Kesner JS; Wright DM; Schrader SM; Chin NW; Krieg EF
Reprod Toxicol; 1992; 6(5):385-400. PubMed ID: 1463919
[TBL] [Abstract][Full Text] [Related]
11. Application of a method for estimating day of ovulation using urinary estrogen and progesterone metabolites.
Baird DD; McConnaughey DR; Weinberg CR; Musey PI; Collins DC; Kesner JS; Knecht EA; Wilcox AJ
Epidemiology; 1995 Sep; 6(5):547-50. PubMed ID: 8562634
[TBL] [Abstract][Full Text] [Related]
12. Luteal phase progesterone excretion in ovulatory women with polycystic ovaries.
Joseph-Horne R; Mason H; Batty S; White D; Hillier S; Urquhart M; Franks S
Hum Reprod; 2002 Jun; 17(6):1459-63. PubMed ID: 12042261
[TBL] [Abstract][Full Text] [Related]
13. Detecting evidence of luteal activity by least-squares quantitative basal temperature analysis against urinary progesterone metabolites and the effect of wake-time variability.
Bedford JL; Prior JC; Hitchcock CL; Barr SI
Eur J Obstet Gynecol Reprod Biol; 2009 Sep; 146(1):76-80. PubMed ID: 19552997
[TBL] [Abstract][Full Text] [Related]
14. The majority of irregular menstrual cycles in adolescence are ovulatory: results of a prospective study.
Peña AS; Doherty DA; Atkinson HC; Hickey M; Norman RJ; Hart R
Arch Dis Child; 2018 Mar; 103(3):235-239. PubMed ID: 28794095
[TBL] [Abstract][Full Text] [Related]
15. Direct measurement of pregnanediol 3-glucuronide (PDG) in dried urine spots by liquid chromatography-mass spectrometry to detect ovulation.
Handelsman DJ; Nimmagadda R; Desai R; Handelsman TD; Whittle B; Skorupskaite K; Anderson RA
J Steroid Biochem Mol Biol; 2021 Jul; 211():105900. PubMed ID: 33872762
[TBL] [Abstract][Full Text] [Related]
16. Assessment of anovulation in eumenorrheic women: comparison of ovulation detection algorithms.
Lynch KE; Mumford SL; Schliep KC; Whitcomb BW; Zarek SM; Pollack AZ; Bertone-Johnson ER; Danaher M; Wactawski-Wende J; Gaskins AJ; Schisterman EF
Fertil Steril; 2014 Aug; 102(2):511-518.e2. PubMed ID: 24875398
[TBL] [Abstract][Full Text] [Related]
17. Monitoring of ovarian activity by measurement of urinary excretion rates using the Ovarian Monitor, Part IV: the relationship of the pregnanediol glucuronide threshold to basal body temperature and cervical mucus as markers for the beginning of the post-ovulatory infertile period.
Blackwell LF; Vigil P; Alliende ME; Brown S; Festin M; Cooke DG
Hum Reprod; 2016 Feb; 31(2):445-53. PubMed ID: 26677961
[TBL] [Abstract][Full Text] [Related]
18. Suppression of ovarian function with the transdermally given synthetic progestin ST 1435.
Laurikka-Routti M; Haukkamaa M; Lähteenmäki P
Fertil Steril; 1992 Oct; 58(4):680-4. PubMed ID: 1426309
[TBL] [Abstract][Full Text] [Related]
19. Effects of postovulatory estradiol benzoate administration on women's ovarian function.
Oriol-Bosch A; Cortés J
Fertil Steril; 1975 May; 26(5):405-12. PubMed ID: 1126465
[TBL] [Abstract][Full Text] [Related]
20. Ovarian function after the menarche and hormonal contraception.
Borsos A; Lampé L; Balogh A; Csoknyay J; Ditròi F; Székely P
Int J Gynaecol Obstet; 1988 Oct; 27(2):249-53. PubMed ID: 2903093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
